Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002563 · ClinicalTrials.gov registry record
SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
A clinical trial, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- 263
- Enrollment target
NCT00002563: Completed study, sponsored by SWOG Cancer Research Network.
NCT00002563 is a clinical trial that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 263 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002563 has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- 263 participants
- Enrollment target
Study Summary
RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I or stage II Hodgkin's disease who are receiving radiation therapy with or without chemotherapy.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE psychosocial assessment and care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 1994-04 |
| Est. Completion | 2005-05 |
What the finished NCT00002563 record still lists
NCT00002563 is an observational study that tracks outcomes without assigning an intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT00002563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002563 about?
NCT00002563 is a clinical study titled "SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease". RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I...
What is the current status of trial NCT00002563?
This trial is currently completed. The enrollment target is 263 participants. The study started on 1994-04. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00002563?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE).
Who is sponsoring clinical trial NCT00002563?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia